Nuvation Bio (NUVB) Stock: Buy, Sell, or Hold?
$4.07
-0.22 (-5.13%)
▼
5d:
-2.86%
30d:
-13.03%
90d:
-34.57%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect NUVB Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (57%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$4.37 – $4.87
Position: OVERSOLD
Forward P/E & Valuation
-36.2x
CHEAP
vs 86.0x historical avg
Wall Street Target
$12.45
+190.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.98 / $4.85
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: NUVB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When NUVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NUVB is currently trading at $4.07, which is considered oversold relative to its 30-day fair value range of $4.37 to $4.87. From a valuation perspective, the stock is trading at a discount (Forward PE: -36.2) compared to its historical average (86.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NUVB is in a strong downtrend. The price is currently testing key support at $3.98. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: NUVB scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.45 (+190.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUVB is in a strong downtrend. The price is currently testing key support at $3.98. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: NUVB scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.45 (+190.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.37 -
$4.87
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Trading Range & Key Levels
30-Day Trading Range
$4.37 -
$4.87
Current vs Trading Range
OVERSOLD
Support Level
$3.98
Resistance Level
$4.85
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding NUVB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 190.3% below Wall St target ($12.45)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Fundamental Context
Forward P/E (Next Year Est.)
-36.23
Wall Street Target
$12.45
(+190.3%)
Revenue Growth (YoY)
242.6%
Profit Margin
-67.4%
PE vs Historical
-36.2 vs 86.0
CHEAP
Share NUVB Analysis
Share this live NUVB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NUVB)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Nuvation Bio (NUVB) announced that its executives will present at the Jefferies Global Healthcare Conference in London, with a live webcast and archived recording available.
Key Retail Themes:
Company news
Upcoming investor presentations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:43 PM ET
Data refreshes hourly during market hours. Next update: 2:43 PM
Data refreshes hourly during market hours. Next update: 2:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
Advanced NUVB Option Strategies
Professional options setups generated by AI based on today's NUVB price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NUVB Research Pages